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Abstract
Background: Plasmodium vivax infections seldom kill directly but do cause indirect mortality by reducing birth weight and
causing abortion. Cytoadherence and sequestration in the microvasculature are central to the pathogenesis of severe
Plasmodium falciparum malaria, but the contribution of cytoadherence to pathology in other human malarias is less clear.
Methodology: The adherence properties of P. vivax infected red blood cells (PvIRBC) were evaluated under static and flow
conditions.
Principal Findings: P. vivax isolates from 33 patients were studied. None adhered to immobilized CD36, ICAM-1, or
thrombospondin, putative ligands for P. falciparum vascular cytoadherence, or umbilical vein endothelial cells, but all
adhered to immobilized chondroitin sulphate A (CSA) and hyaluronic acid (HA), the receptors for adhesion of P. falciparum
in the placenta. PvIRBC also adhered to fresh placental cells (N=5). Pre-incubation with chondroitinase prevented PvIRBC
adherence to CSA, and reduced binding to HA, whereas preincubation with hyaluronidase prevented adherence to HA, but
did not reduce binding to CSA significantly. Pre-incubation of PvIRBC with soluble CSA and HA reduced binding to the
immobilized receptors and prevented placental binding. PvIRBC adhesion was prevented by pre-incubation with trypsin,
inhibited by heparin, and reduced by EGTA. Under laminar flow conditions the mean (SD) shear stress reducing maximum
attachment by 50% was 0.06 (0.02) Pa but, having adhered, the PvIRBC could then resist detachment by stresses up to 5 Pa.
At 37uC adherence began approximately 16 hours after red cell invasion with maximal adherence at 30 hours. At 39uC
adherence began earlier and peaked at 24 hours.
Significance: Adherence of P. vivax-infected erythrocytes to glycosaminoglycans may contribute to the pathogenesis of
vivax malaria and lead to intrauterine growth retardation.
Citation: Chotivanich K, Udomsangpetch R, Suwanarusk R, Pukrittayakamee S, Wilairatana P, et al. (2012) Plasmodium vivax Adherence to Placental
Glycosaminoglycans. PLoS ONE 7(4): e34509. doi:10.1371/journal.pone.0034509
Editor: Lars Hviid, University of Copenhagen, Denmark
Received February 27, 2012; Accepted March 6, 2012; Published April 17, 2012
Copyright:  2012 Chotivanich et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Faculty of Tropical Medicine, Mahidol University and The Wellcome Trust. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nickw@tropmedres.ac
Introduction
Vital organ dysfunction and death from P falciparum malaria
results from microvascular obstruction caused by the sequestration
of red cells containing mature forms of the parasite. P.falciparum
infections in pregnancy are associated with a consistent reduction
in birth weight, particularly in primigravidae. This is a major risk
factor for neonatal death. Intrauterine growth retardation is
associated with the accumulation of P.falciparum infected red cells
in the placenta. This accumulation results from the adherence of
a specific and relatively conserved red cell surface expressed
domain of the antigenically variant membrane protein (PfEMP1)
to the placental glycosaminoglycan chondroitin sulphate A, and to
secondary receptors such as hyaluronic acid and immunoglobulins
[1–5]. Plasmodium vivax is generally regarded as a more benign
parasite than P.falciparum, and is associated with a lower mortality,
although severe forms may occur occasionally [6]. P.vivax accounts
for approximately half of all malaria outside Africa [7]. Like
P.falciparum, P.vivax has also exerted a considerable selective
pressure on human evolution although pathological processes
are less well understood. Plasmodium vivax causes rosetting
(adherence to uninfected erythrocytes) [8] but until recently it
has not been considered to cytoadhere [9]. P. vivax infections in
pregnancy also cause abortions [10] and reduce birthweight which
increases the risk of neonatal death, although the mechanism
underlying early fetal loss or the intrauterine growth retardation is
unclear [11]. We have investigated the adherence of P. vivax
(N=33) to the placental glycosaminoglycans chondroitin sulphate
A (CSA) and hyaluronic acid (HA), the putative receptors for P.
falciparum placental adherence [10,11].
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Ethics statement
This study was a part of clinical studies which have been
approved by the Ethics Committee, Faculty of Tropical Medicine,
Mahidol University. All participants gave fully informed consent to
providing a 5 mL blood sample. Written informed consent was
provided by study participants.
Parasites
Synchronous fresh isolates (.80% ring stage) of Plasmodium vivax
were obtained from non-pregnant adult patients with acute vivax
malaria admitted to the Hospital for Tropical diseases, Bangkok
and entered into clinical studies. Malaria parasite species were
confirmed by PCR [12]. All blood samples were recorded using
a code identifier, and the subsequent experiments were conducted
and the results were interpreted blinded to the patient data. Blood
samples were taken into heparinized tubes and cultured as
described previously [13]. Briefly, blood samples were centrifuged
at 500 g at 4uC then plasma was discarded. White blood cells were
removed by a CF-11 column or PlasmodipurH filter. After
24 hours of cultivation, trophozoite-infected red cells were used
for further experiments. The parasite density of clinical isolates
with less than 0.5% parasitaemia was augmented by concentration
using a 66% PercollH gradient [14] or a magnetic separation
column [15]. The synchronous trophozoite-IRBCs were enriched
to 80–90% parasitaemia and the concentrate then adjusted to 1%
parasitaemia at 1% haematocrit in PV-MCM media for the static
adherence assay [16,17], and to 2% Haematocrit in 1% albumax
for the laminar sheer flow adherence assay. Highly synchronized
ring stage parasites (.0.5% parasitaemia) were used for assessing
the relationship between adherence and stage of parasite de-
velopment. The P. falciparum A4 clone, selected for adhesion to
CSA (kindly provided by Dr David Roberts) was used as the
control. Rosette formation (the adherence of two or more
uninfected red cells to the infected cells) was counted for 100
IRBCs as described previously [18].
Static adherence assay
Adherence of parasitized erythrocytes to umbilical vein
endothelial cells was assessed as described previously [19]. The
reagents evaluated as potential receptors in the adherence assay
were: purified CD36 and ICAM-1 (kindly provided by Arnab
Pain), Thrombospondin (TSP; provided by Rachanee Udomsang-
petch), CSA (from bovine trachea Sigma@ cat no C8529, or CSA
covalently linked to phosphatidylethanolamine, kindly provided by
Stephen Rogerson), CSC (chondroitin sulphate C), de-6-O-
sulphated CSA [20], dextran sulphate with molecular weight of
500 kD (Sigma), and HA (from bovine vitreous humor, Sigma
@
cat no H7630). Assessment of adherence to these receptors was
performed as described previously [20]. Briefly, receptors (at
100 ug/mL) were coated on plastic Petri dishes for 24 hours at
4uC, and then blocked by 1% bovine serum albumin in phosphate
buffer saline (PBS) before being used. The IRBC suspension was
incubated with the immobilized receptor spots for 30 minutes, at
37uC. After that, unbound red cells were removed by gently
washing with RPMI-HEPES. The adherent cells were fixed with
glutaraldehyde, and stained with Giemsa. The number of IRBCs
bound was counted per 100 high power fields or 1 mm
2.
Factors reducing P. vivax-infected red cell adherence
Soluble CSA (50 ug/mL) and HA (50 ug/mL) were incubated
with the IRBC suspensions for 15 minutes at 37uC and the red
cells then resuspended before testing adherence. In order to
characterize further the adherence properties of PvIRBC, the
effects of heparin (Leo
H 1–1000 units/mL) and EGTA (0.01–
1 mM) on adherence were assessed by coincubation for 2 hours at
37uC before the adherence assays were performed. In separate
experiments, parasite cultures were coincubated with trypsin (1 to
1000 ug/mL; Sigma) for 15 minutes at 37uC, then washed and
resuspended in PV-MCM culture medium containing 10% human
serum and tested in the adherence assay as described above.
P.vivax adherence to HA and CSA was evaluated further by
incubating the Petri dishes with chondroitinase ABC (5 units/mL)
and testicular hyarulonidase (10 unit/mL) or without enzyme
(control) at 37uC for 45 minutes. The number of bound IRBCs
was counted per 100 high power fields or 1 mm
2. The median and
ranges of adherence cell numbers were calculated.
Stage of P. vivax development and adherence to CSA
and HA
The relationship between P. vivax IRBC adherence and stage of
parasite development was investigated in ten isolates during the 48
hour asexual blood stage cycle in vitro. Parasite ring stages (6 hour
old) were cultured as described previously [13], in 5% CO2 at 37
uC and 39uC in parallel. Thin blood films were prepared every
6 hours up to 42 hours of parasite development and stained with
Field’s stain. In the static adherence assay the number of CSA and
HA adherent IRBCs per 1000 red cells was counted every six
hours and parasite developmental stage evaluated in 100 infected
cells using staging criteria described previously [13].
P. vivax IRBC adherence to fresh placental sections
The Stamper-Woodruff adherence assay [21] was performed
with some modification for the assessment of placental adhesion.
Freshly frozen normal placenta sections (10 mm thick) were placed
on glass slides and fixed with 3% glutaraldehyde in PBS for
30 minutes, then washed with RPMI-1640, kept wet and then
placed on a tray. The concentrated P.vivax infected red cell (P.v
IRBC) suspension at 80% parasitaemia and 1% haematocrit was
overlaid on the slides and incubated for 30 minutes at 37uCi n
5%CO2. After incubation, non-adherent cells were removed by
rinsing with RMPI-1640. The remaining adherent cells were fixed
with 3% glutaraldehyde in PBS and stained with Giemsa.
Placenta-adherent P.v IRBCs binding in the intervillous space
and along the syncytiotrophoblast layer were counted under light
microscopy from 50 high power fields. Uninfected red cell
suspensions (1% haematocrit) overlaid on the placenta sections
served as controls in each assay. The specific adhesion of the
infected red cells on placenta was further investigated by
incubating IRBC suspensions with soluble CSA (50 ug/mL) and
HA (50 ug/mL) for 15 minutes at 37uC before testing adherence.
Pv IRBC adherence under laminar flow conditions
The strength of P.vivax infected red cell adhesion was assessed
under laminar flow conditions. An infusion/withdrawal pump
(Harvard II apparatusH,) infused the cell suspension through
microslides (placed on the stage of the inverted microscope) at
defined flow rates and hence, defined wall shear stresses (calculated
from the dimensions of the microslides and the flow rate, the
temperature and the viscosity of the suspension.) as described
previously [22]. The microslides were coated with 5 mg/mL poly-
L-lysine for 30 minutes, then coated overnight with CSA [22,23].
The coated slides were blocked with 1% bovine serum albumin in
PBS before performing the adherence assays. PBS was used as the
control. Red cell suspensions (1% albumaxH in RPMI-1640)
containing 2610
8 red cells/mL and P.vivax trophozoites
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microslides at a shear stress of 0.05 Pa, for 5 minutes. Non-
adherent cells were removed by perfusion with 1% albumax in
RPMI-1640 for 5 minutes. After removing the non-adherent cells,
the adherent cells were counted per 120 mm
2 surface area. Six
P.vivax isolates were evaluated. CSA-adherent P. falciparum
parasites derived from clone A4, were used as positive controls.
The force of adhesion was then assessed under increasing shear
stresses (0.01 to 8 Pa.). The already adherent cells (10 infected cells
per isolate) were exposed to step-wise increases in shear stress until
the cells were detached.
Statistical methods
Comparisons were performed using the Mann Whitney U test,
proportions using the Chi-squared test and the correlation
between the levels of adherence to different receptors was assessed
using the Spearman Rank correlation coefficient. These were
calculated using SPSS (version 11.5).
Results
In total 33 fresh P. vivax isolates were obtained from adults with
acute vivax malaria. Admission parasitaemias ranged from 0.3–
2.8%. P.falciparum coinfection was excluded by both microscopy
and PCR genotyping in each case. The mean (SD) parasitaemia
was 0.7 (0.3) %. Of 33 isolates 30 (93%) formed rosettes. The
mean (SD) number of infected red cells (IRBCs) forming rosettes
was 21 (17) per 100 infected red cells.
Binding to putative receptors
None of the P.vIRBCs adhered to immobilized CD36, ICAM-1,
or thrombospondin, the putative vascular receptors for P.falci-
parum, whereas all 33 P.vivax isolates adhered to immobilized CSA
and HA. The mean (SD) level of adhesion to CSA was 40 (25) and
to HA was 33 (21) P.vivax infected red blood cells (P.v IRBCs)
bound /mm
2 (Fig. 1). The levels of adherence to CSA and HA
were correlated strongly (rs=0.95; p,0.001). Bland –Altman
analysis gave a mean (95% confidence interval) difference of 7.6
(4.65 to 10.54) P.v IRBCs bound /mm
2 from the average adhesion
to the two receptors. None of the parasite isolates bound to human
umbilical vein endothelial cells (data not shown), chondroitin
sulphate-C, or dextran 500. There was no correlation between the
number of P.v IRBC rosettes formed and adherence to CSA and
HA. Adherence of P. vivax IRBCs to fresh placenta sections was
assessed in five isolates, all of which showed attachment (Fig. 2).
The mean (SD) number of bound P.v IRBCs per mm
2 was 52 (19).
Specificity of PvIRBC adherence
In order to determine the specificity of adherence both CSA
and HA were pretreated with chondroitinase ABC (0.5 and
1 unit/mL) or hyaluronidase (5 and 10 units/mL) (n=21).
Chondroitinase ABC at 0.5 unit/mL almost abolished P.v IRBC
adherence to CSA (median 98%; range 91–100%; p,0.01) and
reduced binding to HA (median 50%; range 15–77%; p,0.01).
Hyaluronidase completely inhibited P.v IRBC binding to HA, not
to CSA (p,0.01; Fig. 3A, B). Adherence to CSA (n=7) was also
inhibited by pre-incubation with soluble CSA (50 ug/mL); median
75% (range 52–95%); p,0.01, and adherence to HA (n=7) was
inhibited by soluble HA (10 ug/mL); median 71% (range 61–
90%) (p,0.01; Fig. 3C, D).
Effects of trypsin, heparin and EGTA
Proteolysis of P.v IRBC surface proteins by high concentrations
of trypsin (.10 ug/mL) completely inhibited adherence. Lower
concentrations (1–10 ug/mL) decreased P.v IRBC binding to CSA
(n=32) and HA (n=20) by more than 50% (ranges 30–99% and
38–90%, respectively) (p,0.01; Fig. 4A, B). Heparin inhibited P.v
IRBC adherence to CSA and HA; 50% inhibition of adherence to
CSA and HA was obtained with 1 unit/mL of heparin (n=32;
range of inhibition 41 to 65%) and .10 unit/mL completely
inhibited adherence (p,0.01; Fig. 4C). P. vivax isolates did not
bind to heparin coated plates. High concentrations (1 mM) of the
calcium chelator EGTA inhibited P.v IRBC adherence to CSA;
median 60% range 57–63% (n=32), and to HA; median 70%
range 65–75% (n=20) (p,0.01; Fig. 4D), but lower concentra-
tions (0.01–0.1 nM) had no significant effects.
Effects of parasite incubation temperature on adhesion
properties
At an incubation temperature of 37uC adherence to CSA and
HA began when the P.vivax parasites reached the large ring stage
of development (approximately 12–16 hours after invasion).
Adherence reached mean (SD) maximum values at 30 hours
(n=10); CSA 36 (10) and HA 41 (8) P.v IRBCs bound per mm
2
respectively. At 39uC adherence began earlier and reached peak
values at 24 hours; CSA 45 (2) and HA 46 (3) per mm
2
respectively (Fig. 5A, B).
P.v IRBC adhesion under laminar flow conditions
In the in vitro laminar flow assay P.v IRBC adherence to CSA
occurred only at low shear stresses (6 parasite isolates; 40 P.v IRBC
each assessed). Maximum values were obtained at 0.01 Pa (Fig. 6).
There was less adhesion at 0.1 Pa and none when shear stresses
increased to 0.2 Pa. The mean (SD) shear stress reducing
maximum attachment by 50% was 0.06 (0.02) Pa. However once
they had adhered the P.v IRBCs were more resistant to
mechanical detachment; most (34 out of 40) were detached after
exposed to 1 Pa shear stresses (for 5 minutes), but 6 out of 40 P.v
IRBCs resisted detachment by shear stresses of up to 5 Pa, for
5 minutes. Pre-incubation of Pv IRBCs with soluble CSA before
perfusion (n=3) totally inhibited parasite binding (p,0.01).
Figure 1. Numbers of P.vivax infected erythrocytes bound to
immobilised potential cytoadherence receptors. HA; hyaluronic
acid, CSA: chondroitin sulphate A, TSP: thrombospondin. Numbers are
mean values and error bars are standard deviations.
doi:10.1371/journal.pone.0034509.g001
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Plasmodium vivax is generally considered to produce debilitating
but non-fatal relapsing infections. Recent case series suggest this
relatively benign reputation may need some revision [6]. Low
birth weight, malnutrition, developmental retardation, severe
anaemia, acute pulmonary oedema and encephalopathy are all
well documented with vivax malaria [6,24–26]. P.vivax has not
previously been considered to sequester in the microcirculation
through cytoadherence of infected erythrocytes, although recent
physiological studies of pulmonary gas transfer in vivax malaria
might be explained by pulmonary sequestration [27]. Conse-
quently severe manifestations have been generally ascribed to
other pathological processes, such as high systemic concentrations
of pro-inflammatory cytokines. This study conducted in Thailand
confirms that Plasmodium vivax infected erythrocytes do not
cytoadhere to the principal vascular endothelial ligands responsi-
ble for P.falciparum sequestration in the microvasculature, or to
Figure 2. P.vivax infected red blood cells (arrows) adherent to the surface of fresh placenta.
doi:10.1371/journal.pone.0034509.g002
Figure 3. Specific adhesion of P.vivax infected red blood cells (P.v IRBC) to immobilised potential receptors and the effects of
enzyme pretreatment and preincubation with soluble receptors. (A) Chondroitin sulphate A (CSA) was pretreated with chondroitinase ABC
(0.5, 1 unit/mL). (B) Hyaluronic acid (HA) was pretreated with hyaluronidase (5, 10 units /mL). (C) P.v IRBCs were pre-incubated with soluble CSA
(50 ug/mL). (D) P.v IRBCs were pre-incubated with soluble HA (50 ug/mL). Data are presented as medians with 95% confidence intervals.
doi:10.1371/journal.pone.0034509.g003
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CSA and HA, the placental syncytiotrophoblast glycosaminogly-
cans responsible for P.falciparum sequestration in the placenta [1–
5,28–30]. Similar findings have recently been reported from South
America [9]. P.v IRBC also adhered to fresh placental cells,
although binding was not intense. Malaria reduces birthweight
and this reduces infant survival [11,31]. In P.falciparum infections
this is associated with placental sequestration [1,2]. The data
presented here suggest that the adverse effects of vivax malaria on
intrauterine development may have a similar pathogenesis, and
raise the possibility that pathology in other organs (such as lung
capillaries and venules in patients who develop pulmonary
Figure 4. Effects of trypsin pre-incubation, heparin and EGTA on the adhesion of P.vivax infected red blood cells to immobilised
CSA and HA. (A) Effects of pre-incubation with trypsin on adhesion to CSA. (B) Effects of pre-incubation with trypsin on adhesion to HA. (C) Effects
of heparin on binding to immobilized CSA and HA. Black bars: CSA, Grey bars: HA. (D) Effects of EGTA on binding to immobilized CSA and HA. Black
bars: CSA, Grey bars: HA. Data are presented as medians with 95% confidence intervals.
doi:10.1371/journal.pone.0034509.g004
Figure 5. The effects of temperature on the development of Plasmodium vivax adherence properties. (A) Asexual development in
synchronous in-vitro culture at 37uC, the peak of adhesion appears at approximately 30 hours of intraerythrocytic development. (B)A t3 9 uC, peak
adhesion appears at approximately 24 hours of intraerythrocytic development.
doi:10.1371/journal.pone.0034509.g005
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chondroitin sulphate (CSA).
All isolates bound both CSA and HA to some extent although
the degree of adhesion to the two receptors was different with
some isolates. The specificity of adherence to these glycosamino-
glycan receptors is supported by the inhibition by pretreatment
with hyaluronidase and chondroitinase and competitive blocking
by the soluble purified glycosaminoglycans under static and flow
conditions [28–30]. Soluble CSA blocked binding to placental
sections supporting a primary role for this molecule in placental
cytoadherence. Commercial preparations of HA have been
contaminated by CSA so the precise nature of the interaction
with these two glycosaminoglycans remains to be elucidated.
P.vIRBC adhesion to CSA and HA was inhibited by heparin, but
was relatively resistant to cation depletion (EGTA), suggesting
charge might contribute to non-specific inhibitory effects.
P.falciparum cytoadherence is prevented by trypsin. PvIRBC
adherence to CSA and HA was also largely abolished by trypsin
indicating a red cell surface protein –receptor interaction [1–3,6],
but the identity of this protein remains to be identified. The
different sensitivities to trypsin among the different isolates may
indicate different levels of adhesive surface protein expression,
different adhesins, or multiple domains of the same adhesive
molecules, as observed for P. falciparum binding to both CD36 and
ICAM-1 [32].
P.v IRBC cytoadherence had other properties which are similar
to that of P.falciparum. The IRBCs began to cytoadhere at the end
of the first third of the asexual cycle, at the large ring to
trophozoite stage, and this was accelerated by incubation at
a ‘‘febrile’’ temperature (39uC) [33]. Cytoadherence did not occur
at high shear stresses, but once the IRBCs had adhered to CSA or
HA they were relatively resistant to increases in shear stresses up to
5 Pa.
P.vivax reduces birthweight but the causative mechanisms have
been unclear. P.vivax forms rosettes more than P.falciparum, and this
might also contribute to pathological processes in the placenta.
There is very limited information on placental pathology in acute
vivax malaria so the extent of sequestration in-vivo is not known
[34,35]. Adhesion of Plasmodium vivax infected red cells occurred at
the low shear stresses (0.01–0.06 Pa) similar to those encountered
in the intervillous spaces of the placenta. Higher stresses prevail in
the systemic circulation. Given the physical characteristics of the
placental circulation with its large vascular spaces, mechanical
obstruction seems unlikely to account for placental dysfunction.
Inflammatory processes with secondary interference with nutrient
transfer may be more likely. Whichever the mechanism the
evidence from P. falciparum infections that glycosaminoglycans are
an important contributor to placental cytoadherence, and that
antibodies which block this adherence are associated with
protection against the adverse effect of birth weight, strongly
suggests a pathological role [36]. The Duffy binding ligand of
P.falciparum PfEMP1 that mediates cytoadherence to CSA is being
developed as a possible vaccine against pregnancy malaria. A
similar strategy might prevent the adverse effects of vivax malaria
in pregnancy.
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